NCT01251328

Brief Summary

Transcatheter aortic valve implantation (TAVI) is an alternative for patients, that are considered to be too sick for conventional aortic valve replacement. There is no conclusive opinion about the best anesthesiologic management of these patients. Sedation and general anaesthesia are both adequate and the current literature shows no benefit towards one of these methods. This study wants to investigate the influence of these two anesthesiologic managements on the cerebral oxygen saturation during the "rapid pacing"-period during valvuloplasty. The patients are randomised allocated to one of these two anaesthesiological managements. The investigators use the Near-Infrared Spectroscopy (NIRS) to measure the cerebral oxygen saturation. Parallel there will be a measurement of cerebral biomarkers to monitor cerebral hypoxia.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
62

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Dec 2010

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

November 29, 2010

Completed
2 days until next milestone

First Posted

Study publicly available on registry

December 1, 2010

Completed
Same day until next milestone

Study Start

First participant enrolled

December 1, 2010

Completed
1.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2012

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 1, 2012

Completed
Last Updated

February 10, 2015

Status Verified

February 1, 2015

Enrollment Period

1.3 years

First QC Date

November 29, 2010

Last Update Submit

February 9, 2015

Conditions

Outcome Measures

Primary Outcomes (1)

  • Cerebral oxygen desaturation during the "rapid pacing" period and periprocedural

    Biomarkers for cerebral ischemia will be measured up to 48 hours

    up to 48 hours

Study Arms (2)

General anaesthesia

ACTIVE COMPARATOR

General anaesthesia is performed under standardized conditions

Procedure: General anaesthesia

Sedation

ACTIVE COMPARATOR

Sedation is performed under standardized conditions

Procedure: Sedation

Interventions

general anaesthesia is performed according to the hospitals standard

General anaesthesia
SedationPROCEDURE

Sedation is performed according to the hospitals standard

Sedation

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • informed consent
  • transcatheter aortic valve implantation

You may not qualify if:

  • denial by patient
  • denial by screening anaesthesist
  • active neurodegenerative disease

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Deutsches Herzzentrum München

Munich, Bavaria, D-80636, Germany

Location

Related Publications (1)

  • Mayr NP, Hapfelmeier A, Martin K, Kurz A, van der Starre P, Babik B, Mazzitelli D, Lange R, Wiesner G, Tassani-Prell P. Comparison of sedation and general anaesthesia for transcatheter aortic valve implantation on cerebral oxygen saturation and neurocognitive outcomedagger. Br J Anaesth. 2016 Jan;116(1):90-9. doi: 10.1093/bja/aev294. Epub 2015 Sep 29.

MeSH Terms

Conditions

Aortic Valve Stenosis

Interventions

Anesthesia, General

Condition Hierarchy (Ancestors)

Aortic Valve DiseaseHeart Valve DiseasesHeart DiseasesCardiovascular DiseasesVentricular Outflow Obstruction

Intervention Hierarchy (Ancestors)

AnesthesiaAnesthesia and Analgesia

Study Officials

  • Patrick N Mayr, MD

    Deutsches Herzzentrum München, Department of Anaesthesiology, Technische Universität München

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
MD

Study Record Dates

First Submitted

November 29, 2010

First Posted

December 1, 2010

Study Start

December 1, 2010

Primary Completion

April 1, 2012

Study Completion

April 1, 2012

Last Updated

February 10, 2015

Record last verified: 2015-02

Locations